ACM
JAZZ icon

Asymmetry Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Asymmetry Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-52,702
Closed -$9.36M – 39
2021
Q2 		$9.36M Sell
52,702
-21,462
-29% -$3.72M 6.44% 6
2021
Q1 		$12.2M Sell
74,164
-15,725
-17% -$2.59M 6.31% 1
2020
Q4 		$14.8M Buy
89,889
+78,442
+685% +$11.7M 6.76% 3
2020
Q3 		$1.63M Buy
+11,447
New +$1.42M 1.05% 28
2019
Q3 		– Sell
-63,940
Closed -$9.12M – 32
2019
Q2 		$9.12M Buy
+63,940
New +$8.59M 4.94% 8
2018
Q4 		– Sell
-22,144
Closed -$3.72M – 27
2018
Q3 		$3.72M Sell
22,144
-7,481
-25% -$1.29M 3.44% 10
2018
Q2 		$5.1M Sell
29,625
-1,679
-5% -$274K 5.02% 5
2018
Q1 		$4.73M Sell
31,304
-13,672
-30% -$2.01M 5.91% 4
2017
Q4 		$6.06M Buy
44,976
+2,884
+7% +$400K 8.22% 3
2017
Q3 		$6.16M Buy
42,092
+10,753
+34% +$1.63M 7.14% 4
2017
Q2 		$4.87M Sell
31,339
-2,352
-7% -$360K 5.78% 4
2017
Q1 		$4.89M Sell
33,691
-8,906
-21% -$1.16M 6.82% 4
2016
Q4 		$4.64M Buy
42,597
+14,368
+51% +$1.6M 8.64% 4
2016
Q3 		$3.43M Sell
28,229
-11,311
-29% -$1.52M 5.96% 9
2016
Q2 		$5.59M Buy
+39,540
New +$5.83M 10.23% 2

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Asymmetry Capital Management's JAZZ Position: Q3 2021 in Review

Asymmetry Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 52,702 shares — an estimated $9.36M sold.

Asymmetry Capital Management first reported a position in JAZZ in Q2 2016 and held it in 15 quarters. The position peaked at $14.8M in Q4 2020. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Asymmetry Capital Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 52,702 Jazz Pharmaceuticals shares in Q3 2021, an estimated $9.36M.
  • Asymmetry Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Asymmetry Capital Management's Jazz Pharmaceuticals position peaked at $14.8M in Q4 2020.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Asymmetry Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.